|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Ohio Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing OhioLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Athersys Inc
| | | Phone: | (216) 461-9900 | Fax: | (216) 361-9495 | Year Established: | 1995 | Ticker: | ATHX | Exchange: | NASDAQ | Main Contact: | Gil Van Bokkelen, Chairman & CEO | | Other Contacts: | Raymond Starling Ph.D., VP, Clinical Development & Operations Rakesh Ramachandran MS, VP, Head of Information Technology Robert (Willie) Mays Ph.D., VP, Regenerative Medicine Manal Morsy MD Ph.D., Senior VP, Head of Global Regulatory Affairs Laura Campbell, Senior VP, Finance William (B.J.) Lehmann J.D., President & COO John Harrington Ph.D., Executive VP & CSO
| | Company Description | Athersys is an international biotechnology company engaged in the discovery and development of therapeutic product candidates designed to extend and enhance the quality of human life. The Company is developing its MultiStem® cell therapy product, a patented, adult-derived "off-the-shelf" stem cell product, initially for disease indications in the neurological, cardiovascular, and inflammatory and immune disease areas, and has several ongoing clinical trials evaluating this potential regenerative medicine product. Athersys has forged strategic partnerships and a broad network of collaborations to further advance the MultiStem cell therapy toward commercialization. | |
|
|
|
|
|